PMID- 19012000 OWN - NLM STAT- MEDLINE DCOM- 20090619 LR - 20211020 IS - 1355-008X (Print) IS - 1355-008X (Linking) VI - 33 IP - 3 DP - 2008 Jun TI - Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. PG - 300-4 LID - 10.1007/s12020-008-9090-x [doi] AB - Brain-derived neurotrophic factor (BDNF) has emerged as a new element related with insulin resistance and obesity. OBJECTIVE: To evaluate the effect of a 3-month reduced-calorie diet (RCD) on serum BDNF concentrations in overweight and obese subjects. SUBJECTS: Seventeen healthy overweight and obese subjects of both sexes (24 - 48 years, BMI 34.6 +/- 1.1 kg/m2). METHODS: Anthropometry, oral glucose tolerance test (OGTT), lipid levels, and serum BDNF were measured at baseline and at the end of the third month. Reduced-calorie diet was defined as a 25% reduction in energy intake composed of: 55% carbohydrates, 20% proteins, and 25% fat (less than 10% saturated fat and over 10% nonsaturated fat). Refined sugar was not allowed. RESULTS: There was a significant decrease in BMI, waist circumference, body fat percentage, fasting glucose, post-OGTT glucose levels, area under the curve of glucose, and HOMA2-IR after 3 months of RCD. Serum BDNF showed a significant increase (3.97 +/- 0.87 to 6.75 +/- 1.62 ng/ml, P = 0.02). Final serum BDNF correlated negatively with weight (r = -0.51, P = 0.03), and basal post-OGTT insulin correlated positively with final serum BDNF (r = 0.48, P = 0.04). CONCLUSIONS: Serum BDNF increases in insulin-resistant overweight and obese subjects after three months on a RCD. This observation could indicate that BDNF may be modulated in humans through diet composition. FAU - Araya, A Veronica AU - Araya AV AD - Endocrinology Section, Department of Internal Medicine, University of Chile Clinical Hospital, Santos Dumont 999, Independencia, Santiago, Chile. varaya@redclinicauchile.cl FAU - Orellana, Ximena AU - Orellana X FAU - Espinoza, Jaime AU - Espinoza J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Endocrine JT - Endocrine JID - 9434444 RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Adult MH - Body Mass Index MH - Brain-Derived Neurotrophic Factor/*blood MH - *Caloric Restriction MH - Diet, Reducing MH - Female MH - Glucose Tolerance Test MH - Humans MH - Insulin Resistance/*physiology MH - Male MH - Middle Aged MH - Obesity/*blood/diet therapy MH - Overweight/*blood/diet therapy MH - Waist Circumference MH - Weight Loss/physiology MH - Young Adult EDAT- 2008/11/18 09:00 MHDA- 2009/06/20 09:00 CRDT- 2008/11/18 09:00 PHST- 2008/03/10 00:00 [received] PHST- 2008/06/26 00:00 [accepted] PHST- 2008/11/18 09:00 [pubmed] PHST- 2009/06/20 09:00 [medline] PHST- 2008/11/18 09:00 [entrez] AID - 10.1007/s12020-008-9090-x [doi] PST - ppublish SO - Endocrine. 2008 Jun;33(3):300-4. doi: 10.1007/s12020-008-9090-x.